ITI-007 (Lumateperone Tosylate) for Schizophrenia
NCT03817528
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class
Stopped
ITI-007 approved by FDA
Conditions
Schizophrenia
Interventions
DRUG:
ITI-007
Sponsor
New York State Psychiatric Institute
Collaborators
[object Object]